Kane Biotech Inc. announced Gord Froehlich will retire as Chief Executive Officer. The Board has appointed Mark Ahrens-Townsend as President and CEO to replace Froehlich, effective May 11, 2015.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 CAD | 0.00% | -16.67% | +56.25% |
1st Jan change | Capi. | |
---|---|---|
+56.25% | 12.08M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- KNE Stock
- News Kane Biotech Inc.
- Kane Biotech Inc. Announces Management Changes